{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,10]],"date-time":"2026-01-10T19:48:47Z","timestamp":1768074527442,"version":"3.49.0"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,12,1]],"date-time":"2018-12-01T00:00:00Z","timestamp":1543622400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2018,12,14]],"date-time":"2018-12-14T00:00:00Z","timestamp":1544745600000},"content-version":"vor","delay-in-days":13,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000865","name":"Bill and Melinda Gates Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000865","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Retrovirology"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1186\/s12977-018-0460-z","type":"journal-article","created":{"date-parts":[[2018,12,14]],"date-time":"2018-12-14T11:49:20Z","timestamp":1544788160000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Lipid levels, insulin resistance and cardiovascular risk over 96\u00a0weeks of antiretroviral therapy: a randomised controlled trial comparing low-dose stavudine and tenofovir"],"prefix":"10.1186","volume":"15","author":[{"given":"Alinda G.","family":"Vos","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthew F.","family":"Chersich","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kerstin","family":"Klipstein-Grobusch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter","family":"Zuithoff","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michelle A.","family":"Moorhouse","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Samanta T.","family":"Lalla-Edward","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrew","family":"Kambugu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N.","family":"Kumarasamy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Diederick E.","family":"Grobbee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roos E.","family":"Barth","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Willem D.","family":"Venter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,12,14]]},"reference":[{"issue":"10100","key":"460_CR1","doi-asserted-by":"publisher","first-page":"1151","DOI":"10.1016\/S0140-6736(17)32152-9","volume":"390","author":"GBD 2016 Causes of Death Collaborators","year":"2017","unstructured":"GBD 2016 Causes of Death Collaborators. Global, regional, and national age-sex specific mortality for 264 causes of death, 1980\u20132016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet. 2017;390(10100):1151\u2013210.","journal-title":"Lancet"},{"issue":"6","key":"460_CR2","doi-asserted-by":"publisher","first-page":"1754","DOI":"10.1093\/ije\/dyt198","volume":"42","author":"DG Dillon","year":"2013","unstructured":"Dillon DG, Gurdasani D, Riha J, Ekoru K, Asiki G, Mayanja BN, et al. Association of HIV and ART with cardiometabolic traits in sub-Saharan Africa: a systematic review and meta-analysis. Int J Epidemiol. 2013;42(6):1754\u201371.","journal-title":"Int J Epidemiol"},{"issue":"15","key":"460_CR3","doi-asserted-by":"publisher","first-page":"1200","DOI":"10.1136\/heartjnl-2015-309026","volume":"102","author":"JR Kingery","year":"2016","unstructured":"Kingery JR, Alfred Y, Smart LR, Nash E, Todd J, Naguib MR, et al. Short-term and long-term cardiovascular risk, metabolic syndrome and HIV in Tanzania. Heart. 2016;102(15):1200\u20135.","journal-title":"Heart"},{"issue":"6","key":"460_CR4","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1038\/jhh.2015.97","volume":"30","author":"CU Nduka","year":"2016","unstructured":"Nduka CU, Stranges S, Sarki AM, Kimani PK, Uthman OA. Evidence of increased blood pressure and hypertension risk among people living with HIV on antiretroviral therapy: a systematic review with meta-analysis. J Hum Hypertens. 2016;30(6):355\u201362.","journal-title":"J Hum Hypertens"},{"issue":"10","key":"460_CR5","doi-asserted-by":"publisher","first-page":"1495","DOI":"10.1097\/QAD.0000000000001109","volume":"30","author":"E Nou","year":"2016","unstructured":"Nou E, Lo J, Grinspoon SK. Inflammation, immune activation, and cardiovascular disease in HIV. AIDS. 2016;30(10):1495\u2013509.","journal-title":"AIDS"},{"issue":"8","key":"460_CR6","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1001\/jamainternmed.2013.3728","volume":"173","author":"MS Freiberg","year":"2013","unstructured":"Freiberg MS, Chang CC, Kuller LH, Skanderson M, Lowy E, Kraemer KL, et al. HIV infection and the risk of acute myocardial infarction. JAMA Internal Med. 2013;173(8):614\u201322.","journal-title":"JAMA Internal Med"},{"issue":"12","key":"460_CR7","doi-asserted-by":"publisher","first-page":"728","DOI":"10.1038\/nrcardio.2014.167","volume":"11","author":"MV Zanni","year":"2014","unstructured":"Zanni MV, Schouten J, Grinspoon SK, Reiss P. Risk of coronary heart disease in patients with HIV infection. Nat Rev Cardiol. 2014;11(12):728\u201341.","journal-title":"Nat Rev Cardiol"},{"issue":"3","key":"460_CR8","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1016\/j.beem.2011.04.004","volume":"25","author":"MP Dube","year":"2011","unstructured":"Dube MP, Cadden JJ. Lipid metabolism in treated HIV Infection. Best Pract Res Clin Endocrinol Metab. 2011;25(3):429\u201342.","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"issue":"1","key":"460_CR9","first-page":"19","volume":"5","author":"B Clotet","year":"2003","unstructured":"Clotet B, Negredo E. HIV protease inhibitors and dyslipidemia. AIDS Rev. 2003;5(1):19\u201324.","journal-title":"AIDS Rev"},{"issue":"4","key":"460_CR10","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1053\/pcad.2003.3","volume":"45","author":"JH Stein","year":"2003","unstructured":"Stein JH. Dyslipidemia in the era of HIV protease inhibitors. Prog Cardiovasc Dis. 2003;45(4):293\u2013304.","journal-title":"Prog Cardiovasc Dis"},{"issue":"2","key":"460_CR11","doi-asserted-by":"publisher","first-page":"e2385","DOI":"10.1097\/MD.0000000000002385","volume":"95","author":"PZ Sinxadi","year":"2016","unstructured":"Sinxadi PZ, McIlleron HM, Dave JA, Smith PJ, Levitt NS, Haas DW, et al. Plasma efavirenz concentrations are associated with lipid and glucose concentrations. Medicine (Baltimore). 2016;95(2):e2385.","journal-title":"Medicine (Baltimore)"},{"issue":"6","key":"460_CR12","doi-asserted-by":"publisher","first-page":"E1666","DOI":"10.1152\/ajpendo.00550.2006","volume":"292","author":"A Fleischman","year":"2007","unstructured":"Fleischman A, Johnsen S, Systrom DM, Hrovat M, Farrar CT, Frontera W, et al. Effects of a nucleoside reverse transcriptase inhibitor, stavudine, on glucose disposal and mitochondrial function in muscle of healthy adults. Am J Physiol Endocrinol Metab. 2007;292(6):E1666\u201373.","journal-title":"Am J Physiol Endocrinol Metab"},{"issue":"2","key":"460_CR13","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1001\/jama.292.2.191","volume":"292","author":"JE Gallant","year":"2004","unstructured":"Gallant JE, Staszewski S, Pozniak AL, DeJesus E, Suleiman JM, Miller MD, et al. Efficacy and safety of tenofovir DF vs stavudine in combination therapy in antiretroviral-naive patients: a 3-year randomized trial. JAMA. 2004;292(2):191\u2013201.","journal-title":"JAMA"},{"issue":"8","key":"460_CR14","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1089\/aid.2008.0308","volume":"25","author":"JA George","year":"2009","unstructured":"George JA, Venter WD, Van Deventer HE, Crowther NJ. A longitudinal study of the changes in body fat and metabolic parameters in a South African population of HIV-positive patients receiving an antiretroviral therapeutic regimen containing stavudine. AIDS Res Hum Retroviruses. 2009;25(8):771\u201381.","journal-title":"AIDS Res Hum Retroviruses"},{"issue":"11","key":"460_CR15","doi-asserted-by":"publisher","first-page":"1493","DOI":"10.1080\/17512433.2016.1221760","volume":"9","author":"JP Mouton","year":"2016","unstructured":"Mouton JP, Cohen K, Maartens G. Key toxicity issues with the WHO-recommended first-line antiretroviral therapy regimen. Expert Rev Clin Pharmacol. 2016;9(11):1493\u2013503.","journal-title":"Expert Rev Clin Pharmacol"},{"key":"460_CR16","unstructured":"World HO. Antiretroviral therapy for HIV infection in adults and adolescents.\u00a0Recommendations for a public health approach. 2010 revision. 2010."},{"key":"460_CR17","doi-asserted-by":"publisher","DOI":"10.1097\/QAI.0000000000001908","author":"WDF Venter","year":"2018","unstructured":"Venter\u00a0WDF, Kambugu A, Chersich MF, Becker S, Hill A, et al.\u00a0Efficacy and safety of tenofovir disoproxil fumarate versus low-dose\u00a0stavudine\u00a0over 96 weeks: a multi-country randomised, non-inferiority trial. J Acquir Immune Defic Syndr. 2018. \n                    https:\/\/doi.org\/10.1097\/QAI.0000000000001908\n                    \n                  .","journal-title":"J Acquir Immune Defic Syndr."},{"issue":"6","key":"460_CR18","doi-asserted-by":"publisher","first-page":"1487","DOI":"10.2337\/diacare.27.6.1487","volume":"27","author":"TM Wallace","year":"2004","unstructured":"Wallace TM, Levy JC, Matthews DR. Use and abuse of HOMA modeling. Diabetes Care. 2004;27(6):1487\u201395.","journal-title":"Diabetes Care"},{"key":"460_CR19","unstructured":"Framingham Heart Study10-year CVD risk score. \n                    https:\/\/www.framinghamheartstudy.org\/fhs-risk-functions\/cardiovascular-disease-10-year-risk\/\n                    \n                  . Accessed 27 April 2018."},{"issue":"2","key":"460_CR20","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1080\/10543406.2012.755660","volume":"23","author":"J Roy","year":"2013","unstructured":"Roy J. Applied Longitudinal Analysis, Second Edition, by G. M. Fitzmaurice, N. M. Laird, and J. H. Ware. J Biopharm Stat. 2013;23(2):491\u20132.","journal-title":"J Biopharm Stat."},{"issue":"5","key":"460_CR21","first-page":"1045","volume":"74","author":"C Grunfeld","year":"1992","unstructured":"Grunfeld C, Pang M, Doerrler W, Shigenaga JK, Jensen P, Feingold KR. Lipids, lipoproteins, triglyceride clearance, and cytokines in human immunodeficiency virus infection and the acquired immunodeficiency syndrome. J Clin Endocrinol Metab. 1992;74(5):1045\u201352.","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"460_CR22","doi-asserted-by":"publisher","first-page":"e0151911","DOI":"10.1371\/journal.pone.0151911","volume":"11","author":"JA Dave","year":"2016","unstructured":"Dave JA, Levitt NS, Ross IL, Lacerda M, Maartens G, Blom D. Anti-retroviral therapy increases the prevalence of dyslipidemia in South African HIV-infected patients. PLoS ONE. 2016;11(3):e0151911.","journal-title":"PLoS ONE"},{"issue":"4","key":"460_CR23","first-page":"298","volume":"26","author":"F Miedema","year":"2013","unstructured":"Miedema F, Hazenberg MD, Tesselaar K, van Baarle D, de Boer RJ, Borghans JA. Immune activation and collateral damage in AIDS pathogenesis. Front Immunol. 2013;26(4):298.","journal-title":"Front Immunol"},{"issue":"4","key":"460_CR24","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1007\/s11904-016-0321-0","volume":"13","author":"NT Funderburg","year":"2016","unstructured":"Funderburg NT, van Mehta NN. Lipid abnormalities and inflammation in HIV inflection. Curr HIV\/AIDS Rep. 2016;13(4):218\u201325.","journal-title":"Curr HIV\/AIDS Rep"},{"issue":"12","key":"460_CR25","doi-asserted-by":"publisher","first-page":"1820","DOI":"10.1093\/cid\/cit120","volume":"56","author":"E Liu","year":"2013","unstructured":"Liu E, Armstrong C, Spiegelman D, Chalamilla G, Njelekela M, Hawkins C, et al. First-line antiretroviral therapy and changes in lipid levels over 3\u00a0years among HIV-infected adults in Tanzania. Clin Infect Dis. 2013;56(12):1820\u20138.","journal-title":"Clin Infect Dis"},{"issue":"199","key":"460_CR26","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1016\/j.ijcard.2015.07.052","volume":"15","author":"C Nduka","year":"2015","unstructured":"Nduka C, Sarki A, Uthman O, Stranges S. Impact of antiretroviral therapy on serum lipoprotein levels and dyslipidemias: a systematic review and meta-analysis. Int J Cardiol. 2015;15(199):307\u201318.","journal-title":"Int J Cardiol"},{"issue":"6","key":"460_CR27","doi-asserted-by":"publisher","first-page":"380","DOI":"10.5582\/ddt.2015.01207","volume":"9","author":"Q Tang","year":"2015","unstructured":"Tang Q, Li X, Song P, Xu L. Optimal cut-off values for the homeostasis model assessment of insulin resistance (HOMA-IR) and pre-diabetes screening: developments in research and prospects for the future. Drug Discov Ther. 2015;9(6):380\u20135.","journal-title":"Drug Discov Ther"},{"issue":"5","key":"460_CR28","doi-asserted-by":"publisher","first-page":"854","DOI":"10.1007\/s00125-017-4216-4","volume":"60","author":"KA Meeks","year":"2017","unstructured":"Meeks KA, Stronks K, Adeyemo A, Addo J, Bahendeka S, Beune E, et al. Peripheral insulin resistance rather than beta cell dysfunction accounts for geographical differences in impaired fasting blood glucose among sub-Saharan African individuals: findings from the RODAM study. Diabetologia. 2017;60(5):854\u201364.","journal-title":"Diabetologia"},{"issue":"5","key":"460_CR29","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1517\/14656566.8.5.679","volume":"8","author":"A Hill","year":"2007","unstructured":"Hill A, Ruxrungtham K, Hanvanich M, Katlama C, Wolf E, Soriano V, et al. Systematic review of clinical trials evaluating low doses of stavudine as part of antiretroviral treatment. Expert Opin Pharmacother. 2007;8(5):679\u201388.","journal-title":"Expert Opin Pharmacother"},{"issue":"8","key":"460_CR30","doi-asserted-by":"publisher","first-page":"1290","DOI":"10.1086\/529384","volume":"46","author":"GA McComsey","year":"2008","unstructured":"McComsey GA, Lo Re V 3rd, O\u2019Riordan M, Walker UA, Lebrecht D, Baron E, et al. Effect of reducing the dose of stavudine on body composition, bone density, and markers of mitochondrial toxicity in HIV-infected subjects: a randomized, controlled study. Clin Infect Dis. 2008;46(8):1290\u20136.","journal-title":"Clin Infect Dis"},{"issue":"3","key":"460_CR31","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1007\/s40261-014-0266-2","volume":"35","author":"R Quercia","year":"2015","unstructured":"Quercia R, Roberts J, Martin-Carpenter L, Zala C. Comparative changes of lipid levels in treatment-naive, HIV-1-infected adults treated with dolutegravir vs. efavirenz, raltegravir, and ritonavir-boosted darunavir-based regimens over 48\u00a0weeks. Clin Drug Investig. 2015;35(3):211\u20139.","journal-title":"Clin Drug Investig"},{"issue":"7 Suppl","key":"460_CR32","first-page":"S35","volume":"52","author":"SS Anand","year":"2000","unstructured":"Anand SS, Yusuf S, Vuksan V, Devanesen S, Teo KK, Montague PA, et al. Differences in risk factors, atherosclerosis and cardiovascular disease between ethnic groups in Canada: the study of health assessment and risk in ethnic groups (SHARE). Indian Heart J. 2000;52(7 Suppl):S35\u201343.","journal-title":"Indian Heart J"},{"issue":"5","key":"460_CR33","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1161\/CIRCULATIONAHA.113.005757","volume":"129","author":"AT Frank","year":"2014","unstructured":"Frank AT, Zhao B, Jose PO, Azar KM, Fortmann SP, Palaniappan LP. Racial\/ethnic differences in dyslipidemia patterns. Circulation. 2014;129(5):570\u20139.","journal-title":"Circulation"},{"issue":"1","key":"460_CR34","first-page":"89-96.e3","volume":"11","author":"SA Patel","year":"2016","unstructured":"Patel SA, Shivashankar R, Ali MK, Anjana RM, Deepa M, Kapoor D, et al. Is the \u201cSouth Asian phenotype\u201d unique to South Asians?: comparing cardiometabolic risk factors in the CARRS and NHANES studies. Glob Heart. 2016;11(1):89-96.e3.","journal-title":"Glob Heart"},{"issue":"2","key":"460_CR35","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1177\/2047487315579291","volume":"23","author":"N Friis-Moller","year":"2016","unstructured":"Friis-Moller N, Ryom L, Smith C, Weber R, Reiss P, Dabis F, et al. An updated prediction model of the global risk of cardiovascular disease in HIV-positive persons: the Data-collection on Adverse Effects of Anti-HIV Drugs (D:A:D) study. Eur J Prev Cardiol. 2016;23(2):214\u201323.","journal-title":"Eur J Prev Cardiol"}],"container-title":["Retrovirology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12977-018-0460-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12977-018-0460-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12977-018-0460-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,15]],"date-time":"2020-05-15T09:49:15Z","timestamp":1589536155000},"score":1,"resource":{"primary":{"URL":"https:\/\/retrovirology.biomedcentral.com\/articles\/10.1186\/s12977-018-0460-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,12]]},"references-count":35,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["460"],"URL":"https:\/\/doi.org\/10.1186\/s12977-018-0460-z","relation":{},"ISSN":["1742-4690"],"issn-type":[{"value":"1742-4690","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,12]]},"assertion":[{"value":"6 August 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 December 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 December 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"77"}}